These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2848676

  • 1. [Severe chronic Epstein-Barr virus infection with natural killer cell defect].
    Hartung K, Le Blanc S, Franz A, Jacobs R, Wittekind C, Bornkamm GW, Schmidt RE.
    Dtsch Med Wochenschr; 1988 Dec 16; 113(50):1960-3. PubMed ID: 2848676
    [Abstract] [Full Text] [Related]

  • 2. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
    Felton SC, Hoffmann CC, Kreier JP, Glaser R.
    Lab Anim Sci; 1984 Apr 16; 34(2):164-8. PubMed ID: 6328114
    [Abstract] [Full Text] [Related]

  • 3. Syndrome of chronic Epstein-Barr virus infection.
    Kazura JW.
    Compr Ther; 1988 Apr 16; 14(4):4-6. PubMed ID: 2835203
    [No Abstract] [Full Text] [Related]

  • 4. Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients.
    Korcáková L, Kaslík J, Svobodová J, Nozicková M, Horák J, Kocandrle V, Fabián J, Raska I, Lejnar J, Franková V.
    Cor Vasa; 1988 Apr 16; 30(6):435-41. PubMed ID: 2853033
    [Abstract] [Full Text] [Related]

  • 5. [Prevention and therapy of herpesvirus infections].
    Abb J.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb 16; 180(2-3):107-20. PubMed ID: 2986378
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, Ritz J.
    J Immunol; 1987 Nov 15; 139(10):3306-13. PubMed ID: 2824604
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M, Kato M, Ikeno K, Kobayashi T, Miyagawa Y, Komiyama A, Akabane T.
    Clin Exp Immunol; 1987 May 15; 68(2):251-8. PubMed ID: 2820633
    [Abstract] [Full Text] [Related]

  • 9. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P, Zaytoun AM, Lee JH, Fauci AS.
    J Immunol; 1984 Feb 15; 132(2):571-3. PubMed ID: 6197464
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunological disorder against the Epstein-Barr virus infection and prognosis in patients with cervical carcinoma.
    Kitano Y, Fujisaki S, Nakamura N, Miyazaki K, Katsuki T, Okamura H.
    Gynecol Oncol; 1995 May 15; 57(2):150-7. PubMed ID: 7537239
    [Abstract] [Full Text] [Related]

  • 12. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H, Onodera H, Endo M, Maeda F, Chida S, Akasaka T, Sawai T.
    Hum Pathol; 2005 Feb 15; 36(2):212-8. PubMed ID: 15754300
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus infections in hairy cell leukemia patients in the presence of complement-dependent neutralizing antibody.
    Sairenji T, Sullivan JL, Sakamoto K, Spiro RC, Katayama I, Humphreys RE.
    Cancer Res; 1985 Jan 15; 45(1):411-5. PubMed ID: 2981160
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natural killer cell-type body cavity lymphoma following chronic active Epstein-Barr virus infection.
    Ogata M, Imamura T, Mizunoe S, Ohtsuka E, Kikuchi H, Nasu M.
    Am J Hematol; 2003 Jun 15; 73(2):126-30. PubMed ID: 12749015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.
    Rousset F, Souillet G, Roncarolo MG, Lamelin JP.
    Clin Exp Immunol; 1986 Feb 15; 63(2):280-9. PubMed ID: 3009061
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-related primary cutaneous amyloidosis. Successful treatment with acyclovir and interferon-alpha.
    Drago F, Ranieri E, Pastorino A, Casazza S, Crovato F, Rebora A.
    Br J Dermatol; 1996 Jan 15; 134(1):170-4. PubMed ID: 8745909
    [Abstract] [Full Text] [Related]

  • 19. [Chronic fatigue syndrome associated with Epstein-Barr virus infection].
    Parras F, Salvá F, Reina J, Gil J, Portela D, Alomar P.
    Med Clin (Barc); 1989 Apr 29; 92(16):619-22. PubMed ID: 2545980
    [Abstract] [Full Text] [Related]

  • 20. Clinical aspects on Epstein-Barr virus infection.
    Andersson JP.
    Scand J Infect Dis Suppl; 1991 Apr 29; 80():94-104. PubMed ID: 1666450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.